Venus Concept Inc. (NASDAQ:VERO) Short Interest Down 72.1% in March

Venus Concept Inc. (NASDAQ:VERO) was the target of a large decrease in short interest during the month of March. As of March 15th, there was short interest totalling 12,900 shares, a decrease of 72.1% from the February 29th total of 46,300 shares. Based on an average trading volume of 536,300 shares, the short-interest ratio is currently 0.0 days. Currently, 0.3% of the shares of the company are sold short.

Venus Concept Stock Up 4.8 %

Shares of VERO stock opened at $0.74 on Thursday. Venus Concept has a 52-week low of $0.60 and a 52-week high of $4.70. The business has a 50-day simple moving average of $1.03 and a 200-day simple moving average of $1.45. The stock has a market cap of $4.09 million, a PE ratio of -0.11 and a beta of 0.66.

Institutional Trading of Venus Concept

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. HighTower Advisors LLC acquired a new stake in shares of Venus Concept in the first quarter valued at about $31,000. Bank of New York Mellon Corp increased its stake in Venus Concept by 140.2% during the 1st quarter. Bank of New York Mellon Corp now owns 86,578 shares of the company’s stock worth $124,000 after buying an additional 50,530 shares in the last quarter. SVB Financial Group acquired a new position in shares of Venus Concept during the fourth quarter valued at approximately $51,000. Prelude Capital Management LLC lifted its position in shares of Venus Concept by 73.4% in the first quarter. Prelude Capital Management LLC now owns 177,246 shares of the company’s stock valued at $253,000 after acquiring an additional 75,000 shares in the last quarter. Finally, Commonwealth Equity Services LLC boosted its stake in shares of Venus Concept by 1,762.1% in the first quarter. Commonwealth Equity Services LLC now owns 186,208 shares of the company’s stock worth $40,000 after acquiring an additional 176,208 shares during the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

About Venus Concept

Venus Concept Inc, a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.